Article Versions Notes

Zarubaev VV, Garshinina AV, Kalinina NA, Shtro AA, Belyaevskaya SV, Slita AV, Nebolsin VE, Kiselev OI. Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments. Pharmaceuticals. 2011; 4(12):1518-1534. https://doi.org/10.3390/ph4121518

Zarubaev, Vladimir V., Angelica V. Garshinina, Nelly A. Kalinina, Anna A. Shtro, Svetlana V. Belyaevskaya, Alexander V. Slita, Vladimir E. Nebolsin, and Oleg I. Kiselev. 2011. "Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments" Pharmaceuticals 4, no. 12: 1518-1534. https://doi.org/10.3390/ph4121518

Zarubaev, V. V., Garshinina, A. V., Kalinina, N. A., Shtro, A. A., Belyaevskaya, S. V., Slita, A. V., Nebolsin, V. E., & Kiselev, O. I. (2011). Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments. Pharmaceuticals, 4(12), 1518-1534. https://doi.org/10.3390/ph4121518